Kevin Huhn

Canadian medical cannabis firm Tilray eyes global reach in deal with Novartis subsidiary

British Columbia-based Tilray reached an agreement with a subsidiary of Swiss pharmaceutical giant Novartis AG in which the Canadian firm’s medical marijuana will eventually be produced and distributed in countries where MMJ is legal. Tilray’s deal with Quebec-based Sandoz AG is an extension of a letter of intent the companies signed in March to produce co-branded, nonsmokable and noncombustible […]

Read More

Ohio now anticipates some medical cannabis sales in December

A starting point might finally be in sight for Ohio’s long-delayed medical marijuana market. A spokeswoman for the Ohio Department of Commerce said small amounts of cannabis likely will be available for sale before the end of the year. The agency’s Kerry Francis told The Columbus Dispatch that the state’s first harvested marijuana plants are expected […]

Read More

Boost your bottom line with specialty infused cannabis products

It wouldn’t be fall without pumpkin spice, winter without peppermint, spring without strawberries or summer without lemonade.

Marijuana-infused product manufacturers know this, and they’re capitalizing on popular demand among consumers to shake up their product lines with seasonal or limited-release products.

Read More